Daniel P McGee

Title: The Innovative Contributions of Daniel P McGee

Introduction

Daniel P McGee is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of antiviral agents through his innovative research and development. With a total of four patents to his name, McGee has established himself as a key figure in pharmaceutical advancements.

Latest Patents

Among his latest patents, McGee has developed tricyclic derivatives of substituted pyrimidines, which are compounds useful as antiviral agents. The formula for these compounds includes specific variables where X can be oxygen or NH, Y can be hydrogen, iodo, fluoro, methyl, or trifluoromethyl, Z can be hydrogen or fluoro, and Z' is fluoro. The wavy line in the formula indicates that the group may be positioned above or below the plane of the ring. Additionally, he has patented a process for preparing 9-(1,3-dihydroxy-2-propoxymethyl)guanine and 2,6-diamino-9-(1,3-dihydroxy-2-propoxymethyl)purine, along with certain esters thereof. This process and the novel intermediates he developed reduce the number of reaction steps required to prepare these compounds compared to prior methods. The resulting products are also useful as antiviral agents.

Career Highlights

McGee's career has been marked by his work at Syntex (U.S.A.) Inc., where he has contributed to various innovative projects. His expertise in the field of pharmaceuticals has allowed him to make strides in developing effective antiviral compounds.

Collaborations

Throughout his career, McGee has collaborated with notable colleagues, including Julien P Verheyden and John C Martin. These collaborations have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Daniel P McGee's contributions to the field of antiviral agents through his patents and innovative processes highlight his importance as an inventor. His work continues to impact the pharmaceutical landscape positively.